← 產業報告目錄
Plasma Fractionation and Blood Product Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 126報告編號 APO-9d1c08d19c
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Plasma Fractionation and Blood Product market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Plasma Fractionation and Blood Product is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Plasma Fractionation and Blood Product is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Plasma Fractionation and Blood Product include Takeda, RAAS, Octapharma, LFB Group, Kedrion, Hualan Bio, Grifols, CSL and CBPO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Plasma Fractionation and Blood Product market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasma Fractionation and Blood Product Market by Company
Takeda
RAAS
Octapharma
LFB Group
Kedrion
Hualan Bio
Grifols
CSL
CBPO
BPL
Biotest
Plasma Fractionation and Blood Product Segment by Type
Albumin
Immune Globulin
Coagulation Factor
Other
Plasma Fractionation and Blood Product Segment by Application
Immunology
Hematology
Other
Plasma Fractionation and Blood Product Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation and Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation and Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation and Blood Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Plasma Fractionation and Blood Product manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Plasma Fractionation and Blood Product by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Plasma Fractionation and Blood Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Plasma Fractionation and Blood Product Market Size (2021-2032)
2.2.2 Global Plasma Fractionation and Blood Product Sales (2021-2032)
2.2.3 Global Plasma Fractionation and Blood Product Market Average Price (2021-2032)
2.3 Plasma Fractionation and Blood Product by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Albumin
2.3.3 Immune Globulin
2.3.4 Coagulation Factor
2.3.5 Other
2.4 Plasma Fractionation and Blood Product by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Immunology
2.4.3 Hematology
2.4.4 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Plasma Fractionation and Blood Product Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Plasma Fractionation and Blood Product Sales (K Units) of Manufacturers (2021-2026)
3.3 Global Plasma Fractionation and Blood Product Revenue of Manufacturers (2021-2026)
3.4 Global Plasma Fractionation and Blood Product Average Price by Manufacturers (2021-2026)
3.5 Global Plasma Fractionation and Blood Product Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Plasma Fractionation and Blood Product, Product Type & Application
3.8 Global Manufacturers of Plasma Fractionation and Blood Product, Established Date
3.9 Global Plasma Fractionation and Blood Product Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Takeda
4.1.1 Takeda Company Information
4.1.2 Takeda Business Overview
4.1.3 Takeda Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Takeda Plasma Fractionation and Blood Product Product Portfolio
4.1.5 Takeda Recent Developments
4.2 RAAS
4.2.1 RAAS Company Information
4.2.2 RAAS Business Overview
4.2.3 RAAS Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.2.4 RAAS Plasma Fractionation and Blood Product Product Portfolio
4.2.5 RAAS Recent Developments
4.3 Octapharma
4.3.1 Octapharma Company Information
4.3.2 Octapharma Business Overview
4.3.3 Octapharma Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Octapharma Plasma Fractionation and Blood Product Product Portfolio
4.3.5 Octapharma Recent Developments
4.4 LFB Group
4.4.1 LFB Group Company Information
4.4.2 LFB Group Business Overview
4.4.3 LFB Group Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.4.4 LFB Group Plasma Fractionation and Blood Product Product Portfolio
4.4.5 LFB Group Recent Developments
4.5 Kedrion
4.5.1 Kedrion Company Information
4.5.2 Kedrion Business Overview
4.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Kedrion Plasma Fractionation and Blood Product Product Portfolio
4.5.5 Kedrion Recent Developments
4.6 Hualan Bio
4.6.1 Hualan Bio Company Information
4.6.2 Hualan Bio Business Overview
4.6.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Hualan Bio Plasma Fractionation and Blood Product Product Portfolio
4.6.5 Hualan Bio Recent Developments
4.7 Grifols
4.7.1 Grifols Company Information
4.7.2 Grifols Business Overview
4.7.3 Grifols Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Grifols Plasma Fractionation and Blood Product Product Portfolio
4.7.5 Grifols Recent Developments
4.8 CSL
4.8.1 CSL Company Information
4.8.2 CSL Business Overview
4.8.3 CSL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.8.4 CSL Plasma Fractionation and Blood Product Product Portfolio
4.8.5 CSL Recent Developments
4.9 CBPO
4.9.1 CBPO Company Information
4.9.2 CBPO Business Overview
4.9.3 CBPO Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.9.4 CBPO Plasma Fractionation and Blood Product Product Portfolio
4.9.5 CBPO Recent Developments
4.10 BPL
4.10.1 BPL Company Information
4.10.2 BPL Business Overview
4.10.3 BPL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.10.4 BPL Plasma Fractionation and Blood Product Product Portfolio
4.10.5 BPL Recent Developments
4.11 Biotest
4.11.1 Biotest Company Information
4.11.2 Biotest Business Overview
4.11.3 Biotest Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Biotest Plasma Fractionation and Blood Product Product Portfolio
4.11.5 Biotest Recent Developments
5 Global Plasma Fractionation and Blood Product Market Scenario by Region
5.1 Global Plasma Fractionation and Blood Product Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Plasma Fractionation and Blood Product Sales by Region: 2021-2032
5.2.1 Global Plasma Fractionation and Blood Product Sales by Region: 2021-2026
5.2.2 Global Plasma Fractionation and Blood Product Sales by Region: 2027-2032
5.3 Global Plasma Fractionation and Blood Product Revenue by Region: 2021-2032
5.3.1 Global Plasma Fractionation and Blood Product Revenue by Region: 2021-2026
5.3.2 Global Plasma Fractionation and Blood Product Revenue by Region: 2027-2032
5.4 North America Plasma Fractionation and Blood Product Market Facts & Figures by Country
5.4.1 North America Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Plasma Fractionation and Blood Product Sales by Country (2021-2032)
5.4.3 North America Plasma Fractionation and Blood Product Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Plasma Fractionation and Blood Product Market Facts & Figures by Country
5.5.1 Europe Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Plasma Fractionation and Blood Product Sales by Country (2021-2032)
5.5.3 Europe Plasma Fractionation and Blood Product Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Plasma Fractionation and Blood Product Market Facts & Figures by Country
5.6.1 Asia Pacific Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Plasma Fractionation and Blood Product Sales by Country (2021-2032)
5.6.3 Asia Pacific Plasma Fractionation and Blood Product Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Plasma Fractionation and Blood Product Market Facts & Figures by Country
5.7.1 South America Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Plasma Fractionation and Blood Product Sales by Country (2021-2032)
5.7.3 South America Plasma Fractionation and Blood Product Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Plasma Fractionation and Blood Product Market Facts & Figures by Country
5.8.1 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2021-2032)
5.8.3 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Plasma Fractionation and Blood Product Sales by Type (2021-2032)
6.1.1 Global Plasma Fractionation and Blood Product Sales by Type (2021-2032) & (K Units)
6.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2021-2032)
6.2 Global Plasma Fractionation and Blood Product Revenue by Type (2021-2032)
6.2.1 Global Plasma Fractionation and Blood Product Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2021-2032)
6.3 Global Plasma Fractionation and Blood Product Price by Type (2021-2032)
7 Segment by Application
7.1 Global Plasma Fractionation and Blood Product Sales by Application (2021-2032)
7.1.1 Global Plasma Fractionation and Blood Product Sales by Application (2021-2032) & (K Units)
7.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Application (2021-2032)
7.2 Global Plasma Fractionation and Blood Product Revenue by Application (2021-2032)
7.2.1 Global Plasma Fractionation and Blood Product Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2021-2032)
7.3 Global Plasma Fractionation and Blood Product Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Plasma Fractionation and Blood Product Value Chain Analysis
8.1.1 Plasma Fractionation and Blood Product Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Plasma Fractionation and Blood Product Production Mode & Process
8.2 Plasma Fractionation and Blood Product Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Plasma Fractionation and Blood Product Distributors
8.2.3 Plasma Fractionation and Blood Product Customers
9 Global Plasma Fractionation and Blood Product Analyzing Market Dynamics
9.1 Plasma Fractionation and Blood Product Industry Trends
9.2 Plasma Fractionation and Blood Product Industry Drivers
9.3 Plasma Fractionation and Blood Product Industry Opportunities and Challenges
9.4 Plasma Fractionation and Blood Product Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Plasma Fractionation and Blood Product Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Plasma Fractionation and Blood Product Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Plasma Fractionation and Blood Product Revenue of Manufacturers (2021-2026)
Table 9. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Plasma Fractionation and Blood Product Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Plasma Fractionation and Blood Product Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Plasma Fractionation and Blood Product, Product Type & Application
Table 14. Global Plasma Fractionation and Blood Product Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Plasma Fractionation and Blood Product by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Takeda Company Information
Table 19. Takeda Business Overview
Table 20. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Takeda Plasma Fractionation and Blood Product Product Portfolio
Table 22. Takeda Recent Developments
Table 23. RAAS Company Information
Table 24. RAAS Business Overview
Table 25. RAAS Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. RAAS Plasma Fractionation and Blood Product Product Portfolio
Table 27. RAAS Recent Developments
Table 28. Octapharma Company Information
Table 29. Octapharma Business Overview
Table 30. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Octapharma Plasma Fractionation and Blood Product Product Portfolio
Table 32. Octapharma Recent Developments
Table 33. LFB Group Company Information
Table 34. LFB Group Business Overview
Table 35. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. LFB Group Plasma Fractionation and Blood Product Product Portfolio
Table 37. LFB Group Recent Developments
Table 38. Kedrion Company Information
Table 39. Kedrion Business Overview
Table 40. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Kedrion Plasma Fractionation and Blood Product Product Portfolio
Table 42. Kedrion Recent Developments
Table 43. Hualan Bio Company Information
Table 44. Hualan Bio Business Overview
Table 45. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Hualan Bio Plasma Fractionation and Blood Product Product Portfolio
Table 47. Hualan Bio Recent Developments
Table 48. Grifols Company Information
Table 49. Grifols Business Overview
Table 50. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Grifols Plasma Fractionation and Blood Product Product Portfolio
Table 52. Grifols Recent Developments
Table 53. CSL Company Information
Table 54. CSL Business Overview
Table 55. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. CSL Plasma Fractionation and Blood Product Product Portfolio
Table 57. CSL Recent Developments
Table 58. CBPO Company Information
Table 59. CBPO Business Overview
Table 60. CBPO Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. CBPO Plasma Fractionation and Blood Product Product Portfolio
Table 62. CBPO Recent Developments
Table 63. BPL Company Information
Table 64. BPL Business Overview
Table 65. BPL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. BPL Plasma Fractionation and Blood Product Product Portfolio
Table 67. BPL Recent Developments
Table 68. Biotest Company Information
Table 69. Biotest Business Overview
Table 70. Biotest Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Biotest Plasma Fractionation and Blood Product Product Portfolio
Table 72. Biotest Recent Developments
Table 73. Global Plasma Fractionation and Blood Product Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 74. Global Plasma Fractionation and Blood Product Sales by Region (2021-2026) & (K Units)
Table 75. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2021-2026)
Table 76. Global Plasma Fractionation and Blood Product Sales by Region (2027-2032) & (K Units)
Table 77. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2027-2032)
Table 78. Global Plasma Fractionation and Blood Product Revenue by Region (2021-2026) & (US$ Million)
Table 79. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2021-2026)
Table 80. Global Plasma Fractionation and Blood Product Revenue by Region (2027-2032) & (US$ Million)
Table 81. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2027-2032)
Table 82. North America Plasma Fractionation and Blood Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. North America Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units)
Table 84. North America Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units)
Table 85. North America Plasma Fractionation and Blood Product Revenue by Country (2021-2026) & (US$ Million)
Table 86. North America Plasma Fractionation and Blood Product Revenue by Country (2027-2032) & (US$ Million)
Table 87. Europe Plasma Fractionation and Blood Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 88. Europe Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units)
Table 89. Europe Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units)
Table 90. Europe Plasma Fractionation and Blood Product Revenue by Country (2021-2026) & (US$ Million)
Table 91. Europe Plasma Fractionation and Blood Product Revenue by Country (2027-2032) & (US$ Million)
Table 92. Asia Pacific Plasma Fractionation and Blood Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 93. Asia Pacific Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units)
Table 94. Asia Pacific Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units)
Table 95. Asia Pacific Plasma Fractionation and Blood Product Revenue by Country (2021-2026) & (US$ Million)
Table 96. Asia Pacific Plasma Fractionation and Blood Product Revenue by Country (2027-2032) & (US$ Million)
Table 97. South America Plasma Fractionation and Blood Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 98. South America Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units)
Table 99. South America Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units)
Table 100. South America Plasma Fractionation and Blood Product Revenue by Country (2021-2026) & (US$ Million)
Table 101. South America Plasma Fractionation and Blood Product Revenue by Country (2027-2032) & (US$ Million)
Table 102. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 103. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units)
Table 104. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units)
Table 105. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2021-2026) & (US$ Million)
Table 106. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2027-2032) & (US$ Million)
Table 107. Global Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (K Units)
Table 108. Global Plasma Fractionation and Blood Product Sales by Type (2027-2032) & (K Units)
Table 109. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2021-2026)
Table 110. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2027-2032)
Table 111. Global Plasma Fractionation and Blood Product Revenue by Type (2021-2026) & (US$ Million)
Table 112. Global Plasma Fractionation and Blood Product Revenue by Type (2027-2032) & (US$ Million)
Table 113. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2021-2026)
Table 114. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2027-2032)
Table 115. Global Plasma Fractionation and Blood Product Price by Type (2021-2026) & (US$/Unit)
Table 116. Global Plasma Fractionation and Blood Product Price by Type (2027-2032) & (US$/Unit)
Table 117. Global Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (K Units)
Table 118. Global Plasma Fractionation and Blood Product Sales by Application (2027-2032) & (K Units)
Table 119. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2021-2026)
Table 120. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2027-2032)
Table 121. Global Plasma Fractionation and Blood Product Revenue by Application (2021-2026) & (US$ Million)
Table 122. Global Plasma Fractionation and Blood Product Revenue by Application (2027-2032) & (US$ Million)
Table 123. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2021-2026)
Table 124. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2027-2032)
Table 125. Global Plasma Fractionation and Blood Product Price by Application (2021-2026) & (US$/Unit)
Table 126. Global Plasma Fractionation and Blood Product Price by Application (2027-2032) & (US$/Unit)
Table 127. Key Raw Materials
Table 128. Raw Materials Key Suppliers
Table 129. Plasma Fractionation and Blood Product Distributors List
Table 130. Plasma Fractionation and Blood Product Customers List
Table 131. Plasma Fractionation and Blood Product Industry Trends
Table 132. Plasma Fractionation and Blood Product Industry Drivers
Table 133. Plasma Fractionation and Blood Product Industry Restraints
Table 134. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Plasma Fractionation and Blood Product Product Image
Figure 5. Global Plasma Fractionation and Blood Product Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Plasma Fractionation and Blood Product Market Size (2021-2032) & (US$ Million)
Figure 7. Global Plasma Fractionation and Blood Product Sales (2021-2032) & (K Units)
Figure 8. Global Plasma Fractionation and Blood Product Average Price (US$/Unit) & (2021-2032)
Figure 9. Albumin Product Image
Figure 10. Immune Globulin Product Image
Figure 11. Coagulation Factor Product Image
Figure 12. Other Product Image
Figure 13. Immunology Product Image
Figure 14. Hematology Product Image
Figure 15. Other Product Image
Figure 16. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers in 2025
Figure 17. Global Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Plasma Fractionation and Blood Product Players Market Share by Revenue in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Plasma Fractionation and Blood Product Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 21. Global Plasma Fractionation and Blood Product Sales by Region in 2025
Figure 22. Global Plasma Fractionation and Blood Product Revenue by Region in 2025
Figure 23. North America Plasma Fractionation and Blood Product Market Size by Country in 2025
Figure 24. North America Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2032)
Figure 25. North America Plasma Fractionation and Blood Product Revenue Market Share by Country (2021-2032)
Figure 26. United States Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Canada Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Europe Plasma Fractionation and Blood Product Market Size by Country in 2025
Figure 29. Europe Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2032)
Figure 30. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country (2021-2032)
Figure 31. Germany Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. France Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. U.K. Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Italy Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Netherlands Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Nordic Countries Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Asia Pacific Plasma Fractionation and Blood Product Market Size by Country in 2025
Figure 38. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2032)
Figure 39. Asia Pacific Plasma Fractionation and Blood Product Revenue Market Share by Country (2021-2032)
Figure 40. China Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Japan Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. South Korea Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. India Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Australia Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. China Taiwan Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Southeast Asia Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Southeast Asia Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. South America Plasma Fractionation and Blood Product Market Size by Country in 2025
Figure 49. South America Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2032)
Figure 50. South America Plasma Fractionation and Blood Product Revenue Market Share by Country (2021-2032)
Figure 51. Mexico Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Brazil Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Argentina Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country in 2025
Figure 55. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2032)
Figure 56. Middle East and Africa Plasma Fractionation and Blood Product Revenue Market Share by Country (2021-2032)
Figure 57. Turkey Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Saudi Arabia Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. UAE Plasma Fractionation and Blood Product Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2021-2032)
Figure 61. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2021-2032)
Figure 62. Global Plasma Fractionation and Blood Product Price (US$/Unit) by Type (2021-2032)
Figure 63. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2021-2032)
Figure 64. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2021-2032)
Figure 65. Global Plasma Fractionation and Blood Product Price (US$/Unit) by Application (2021-2032)
Figure 66. Plasma Fractionation and Blood Product Value Chain
Figure 67. Plasma Fractionation and Blood Product Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. Plasma Fractionation and Blood Product Industry Opportunities and Challenges
提及公司
TakedaRAASOctapharmaLFB GroupKedrionHualan BioGrifolsCSLCBPOBPLBiotest
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們